X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (57638) 57638
Newsletter (26539) 26539
Book Review (5917) 5917
Publication (3297) 3297
Newspaper Article (2027) 2027
Conference Proceeding (1510) 1510
Book Chapter (112) 112
Dissertation (92) 92
Magazine Article (60) 60
Trade Publication Article (28) 28
Transcript (11) 11
Book / eBook (10) 10
Web Resource (6) 6
Reference (3) 3
Data Set (2) 2
Government Document (2) 2
Journal / eJournal (1) 1
Paper (1) 1
Presentation (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lung cancer, non-small cell (54753) 54753
index medicus (35632) 35632
humans (35179) 35179
cancer (34007) 34007
research (29691) 29691
oncology (25678) 25678
care and treatment (20713) 20713
female (20563) 20563
male (20275) 20275
oncology, experimental (18073) 18073
middle aged (17708) 17708
lung neoplasms - pathology (17687) 17687
aged (17240) 17240
lung cancer (16896) 16896
carcinoma, non-small-cell lung - pathology (16409) 16409
chemotherapy (15143) 15143
lung cancer, small cell (14211) 14211
carcinoma, non-small-cell lung - drug therapy (13529) 13529
non-small cell lung cancer (13283) 13283
lung neoplasms - drug therapy (13208) 13208
prognosis (12159) 12159
adult (11021) 11021
reports (9885) 9885
carcinoma, non-small-cell lung - genetics (9292) 9292
lung neoplasms - genetics (9132) 9132
analysis (9010) 9010
genetic aspects (8941) 8941
metastasis (8732) 8732
respiratory system (8550) 8550
neoplasm staging (8444) 8444
aged, 80 and over (7503) 7503
tumors (7287) 7287
lung neoplasms - mortality (7169) 7169
carcinoma, non-small-cell lung - mortality (7093) 7093
survival (6788) 6788
radiotherapy (6206) 6206
treatment outcome (6203) 6203
lung neoplasms - metabolism (6138) 6138
carcinoma, non-small-cell lung - metabolism (6018) 6018
health aspects (5804) 5804
carcinoma (5613) 5613
surgery (5309) 5309
apoptosis (5302) 5302
mutation (5292) 5292
physical fitness (5121) 5121
antineoplastic combined chemotherapy protocols - therapeutic use (4997) 4997
cell line, tumor (4975) 4975
expression (4954) 4954
development and progression (4908) 4908
hematology, oncology and palliative medicine (4746) 4746
nsclc (4712) 4712
retrospective studies (4672) 4672
drug therapy (4653) 4653
lung neoplasms - surgery (4548) 4548
epidermal growth factor (4545) 4545
carcinoma, non-small-cell lung - surgery (4539) 4539
medical research (4524) 4524
universities and colleges (4464) 4464
gefitinib (4425) 4425
clinical trials (4336) 4336
antineoplastic agents (4295) 4295
survival rate (4230) 4230
antimitotic agents (4191) 4191
adenocarcinoma (4180) 4180
antineoplastic agents - therapeutic use (3969) 3969
survival analysis (3854) 3854
non-small-cell lung cancer (3851) 3851
animals (3770) 3770
medicine, experimental (3693) 3693
cancer therapies (3653) 3653
biochemistry (3647) 3647
patient outcomes (3597) 3597
non-small cell lung carcinoma (3549) 3549
cisplatin (3536) 3536
diagnosis (3371) 3371
gene expression (3341) 3341
immunohistochemistry (3319) 3319
carcinoma, non-small-cell lung - radiotherapy (3306) 3306
patients (3303) 3303
therapy (3264) 3264
lung neoplasms - radiotherapy (3222) 3222
lung neoplasms - therapy (3197) 3197
carcinoma, non-small-cell lung - therapy (3181) 3181
pharmaceutical industry (3153) 3153
erlotinib (3149) 3149
respiratory tract diseases (3128) 3128
radiology, nuclear medicine & medical imaging (3035) 3035
immunotherapy (3022) 3022
disease-free survival (2981) 2981
cell lung-cancer (2846) 2846
proteins (2828) 2828
receptor, epidermal growth factor - genetics (2727) 2727
lung neoplasms - diagnosis (2709) 2709
medicine & public health (2699) 2699
risk factors (2672) 2672
carcinoma, non-small-cell lung - diagnosis (2668) 2668
abridged index medicus (2651) 2651
medical prognosis (2574) 2574
follow-up studies (2567) 2567
mice (2551) 2551
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (84460) 84460
Chinese (1162) 1162
French (461) 461
Japanese (263) 263
German (235) 235
Korean (134) 134
Polish (88) 88
Spanish (68) 68
Turkish (44) 44
Russian (40) 40
Italian (35) 35
Portuguese (34) 34
Czech (17) 17
Hungarian (15) 15
Serbian (7) 7
Icelandic (6) 6
Dutch (5) 5
Croatian (2) 2
Hebrew (2) 2
Romanian (2) 2
Slovak (2) 2
Belarusian (1) 1
Bosnian (1) 1
Bulgarian (1) 1
Danish (1) 1
Lithuanian (1) 1
Norwegian (1) 1
Persian (1) 1
Swedish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
British Journal of Cancer, ISSN 0007-0920, 05/2013, Volume 108, Issue 10, pp. 2021 - 2032
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 09/2016, Volume 22, Issue 18, pp. 4585 - 4593
Journal Article
International Journal of Cancer, ISSN 0020-7136, 12/2011, Volume 129, Issue 11, pp. 2621 - 2631
Journal Article
Annals of Oncology, ISSN 0923-7534, 05/2015, Volume 26, Issue 5, pp. 894 - 901
Background: KRAS mutations are detected in 25% of non-small-cell lung cancer (NSCLC) and no targeted therapies are approved for this subset population.... 
KRAS | MEK inhibitor | NSCLC | Progression-free survival | Trametinib | Docetaxel | SURVIVAL | CRITERIA | EFFICACY | progression-free survival | BEHAVIOR | ADENOCARCINOMAS | trametinib | TYROSINE KINASE INHIBITORS | GROWTH-FACTOR RECEPTOR | ONCOGENE | MEK INHIBITION | ONCOLOGY | docetaxel | MUTATIONS | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Protein Kinase Inhibitors - adverse effects | Taxoids - therapeutic use | Time Factors | Adult | Female | Antineoplastic Agents, Phytogenic - therapeutic use | Taxoids - adverse effects | Antineoplastic Agents, Phytogenic - adverse effects | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | MAP Kinase Kinase 1 - antagonists & inhibitors | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Pyrimidinones - adverse effects | Pyrimidinones - therapeutic use | Kaplan-Meier Estimate | MAP Kinase Kinase 1 - metabolism | Treatment Outcome | MAP Kinase Kinase 2 - metabolism | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Disease-Free Survival | Signal Transduction - drug effects | MAP Kinase Kinase 2 - antagonists & inhibitors | Protein Kinase Inhibitors - therapeutic use | Aged | Biomarkers, Tumor - genetics | Pyridones - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Mutation | Pyridones - adverse effects | Index Medicus | Original
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 11/2011, Volume 6, Issue 11, pp. 1955 - 1959
Journal Article
LUNG CANCER, ISSN 0169-5002, 09/2017, Volume 111, pp. 176 - 181
Objectives: Immunotherapy with the programmed death receptor-1 (PD-1) antibody nivolumab has changed the field of metastatic non-small cell lung cancer (NSCLC)... 
SURVIVAL | Neutrophil-to-Lymphocyte ratio | METAANALYSIS | SOLID TUMORS | Non small cell lung cancer | DOCETAXEL | TRIAL | METASTATIC MELANOMA | ONCOLOGY | Platelet-to-Lymphocyte ratio | RESPIRATORY SYSTEM | Immunotherapy | INFLAMMATION | PLATINUM-BASED CHEMOTHERAPY | EXPERIENCE | Overall survival | IPILIMUMAB
Journal Article
Journal Article